|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 31/137 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/02 | (2006.01) |
| (11) | Patento numeris | 3220909 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15861189.7 |
| Europos patento paraiškos padavimo data | 2015-05-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-01-25 |
| (86) | Numeris | PCT/US2015/028901 |
| Data | 2015-05-01 |
| (87) | Numeris | WO 2016/081027 |
| Data | 2016-05-26 |
| (30) | Numeris | Data | Šalis |
| 201414550618 | 2014-11-21 | US | |
| 201414554988 | 2014-11-26 | US | |
| 201414554947 | 2014-11-26 | US | |
| 201414555085 | 2014-11-26 | US | |
| 201514602177 | 2015-01-21 | US | |
| 201514604397 | 2015-01-23 | US | |
| 201514617624 | 2015-02-09 | US | |
| 201514628062 | 2015-02-20 | US |
| (72) |
TABUTEAU, Herriot, US
|
| (73) |
Antecip Bioventures II LLC,
630 Fifth Avenue, Suite 2000, New York, NY 10111,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bupropionas, skirtas vaisto dekstrometorfano lygio moduliavimui plazmoje |
| BUPROPION FOR MODULATING DRUG PLASMA LEVELS OF DEXTROMETORPHAN |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-04-10 | 11 | 289.00 EUR |
| 2026-05-01 |